Publishing research using ab106077? Please let us know so that we can cite the reference in this datasheet.

ab106077 has been referenced in 7 publications.

  • He C  et al. miR-10b suppresses cell invasion and metastasis through targeting HOXA3 regulated by FAK/YAP signaling pathway in clear-cell renal cell carcinoma. BMC Nephrol 20:127 (2019). PubMed: 30975094
  • Li J  et al. Fibulin-3 knockdown inhibits cervical cancer cell growth and metastasis in vitro and in vivo. Sci Rep 8:10594 (2018). PubMed: 30006571
  • Yang Z  et al. Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts. Cancer Lett 429:66-77 (2018). WB . PubMed: 29746928
  • Liu B  et al. Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway. Biosci Rep 38:N/A (2018). PubMed: 30442873
  • Li L  et al. Dihydroartemisinin up-regulates VE-cadherin expression in human renal glomerular endothelial cells. J Cell Mol Med N/A:N/A (2017). ChIP ; Human . PubMed: 29193726
  • Qi L  et al. TRIM16 suppresses the progression of prostate tumors by inhibiting the Snail signaling pathway. Int J Mol Med 38:1734-1742 (2016). WB ; Human . PubMed: 27748839
  • Karthikeyan S  et al. Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface. Oncotarget 7:69871-69882 (2016). WB . PubMed: 27563818

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up